HomeSPRY • NASDAQ
add
ARS Pharmaceuticals Inc
Previous close
$9.10
Day range
$8.99 - $9.25
Year range
$2.55 - $11.27
Market cap
874.96M USD
Avg Volume
478.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 8.06M | -34.39% |
Net income | -10.29M | 31.21% |
Net profit margin | — | — |
Earnings per share | -0.11 | 31.25% |
EBITDA | -13.18M | 29.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 223.63M | -15.47% |
Total assets | 227.58M | -16.08% |
Total liabilities | 3.72M | -62.99% |
Total equity | 223.87M | — |
Shares outstanding | 96.90M | — |
Price to book | 3.92 | — |
Return on assets | -14.31% | — |
Return on capital | -14.49% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -10.29M | 31.21% |
Cash from operations | -6.71M | 46.01% |
Cash from investing | -8.51M | 92.37% |
Cash from financing | 258.00K | -80.44% |
Net change in cash | -14.96M | 87.80% |
Free cash flow | -2.90M | 38.39% |
About
Founded
2015
Website
Employees
24